This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Vanhaecht K, De Witte K, Sermeus W. The impact of clinical pathways on organisation of care pathways. PhD dissertation, 2007. Katholieke Universiteit Leuven. Available from https://lirias.kuleuven.be/1718750?limo=0 (accessed 27 June2023).VanhaechtKDe WitteKSermeusW.. PhD dissertation,2007.Katholieke Universiteit Leuven. Available from https://lirias.kuleuven.be/1718750?limo=0(accessed 27 June2023).Search in Google Scholar
European Pathway Association. About care pathways. Available from https://e-p-a.org/care-pathways (accessed 27 June 2023).European Pathway Association.. Available from https://e-p-a.org/care-pathways(accessed 27 June 2023).Search in Google Scholar
Letton C, Cheung C, Nordin A. Does an enhanced recovery integrated care pathway (ICP) encourage adherence to prescribing guidelines, accelerate postoperative recovery and reduce the length of stay for gynaecological oncology patients? J Obstetr Gynaecol 2013; 33: 296-297. doi: 10.3109/01443615.2012.758693.LettonCCheungCNordinA.Does an enhanced recovery integrated care pathway (ICP) encourage adherence to prescribing guidelines, accelerate postoperative recovery and reduce the length of stay for gynaecological oncology patients?2013;33:296-297. doi:10.3109/01443615.2012.758693.Open DOISearch in Google Scholar
Aziz EF, Javed F, Pulimi S, et al. Implementing a pathway for the management of acute coronary syndrome leads to improved compliance with guidelines and a decrease in angina symptoms. J Healthc Qual 2012; 34: 5-14. doi: 10.1111/j.1945-1474.2011.00145.x.AzizEFJavedFPulimiS.Implementing a pathway for the management of acute coronary syndrome leads to improved compliance with guidelines and a decrease in angina symptoms.2012;34:5-14. doi:10.1111/j.1945-1474.2011.00145.x.Open DOISearch in Google Scholar
Deneckere S, Euwema M, Lodewijckx C, et al. Better interprofessional teamwork, higher level of organized care, and lower risk of burnout in acute health care teams using care pathways. A cluster randomized controlled trial. Med Care 2013; 51: 99-107. doi: 10.1097/MLR.0b013e3182763312.DeneckereSEuwemaMLodewijckxC.Better interprofessional teamwork, higher level of organized care, and lower risk of burnout in acute health care teams using care pathways. A cluster randomized controlled trial.2013;51:99-107. doi:10.1097/MLR.0b013e3182763312.Open DOISearch in Google Scholar
Tremblay St-Germain A, Devitt KS, Kagedan DJ, et al. The impact of a clinical pathway on patient postoperative recovery following pancreaticoduodenectomy. HPB (Oxford) 2017; 19: 799-807. 10.1016/j.hpb.2017.04.015.Tremblay St-GermainADevittKSKagedanDJ.The impact of a clinical pathway on patient postoperative recovery following pancreaticoduodenectomy.2017;19:799-807.10.1016/j.hpb.2017.04.015.Open DOISearch in Google Scholar
Pound CM, Gelt V, Akiki S, et al. Nurse-driven clinical pathway for inpatient asthma: a randomized controlled trial. Hospital Pediatr 2017; 7: 204–213. doi: 10.1542/hpeds.2016-0150.PoundCMGeltVAkikiS.Nurse-driven clinical pathway for inpatient asthma: a randomized controlled trial.2017;7:204–213. doi:10.1542/hpeds.2016-0150.Open DOISearch in Google Scholar
Ward AJ, Murphy D, Marron R, et al. Designing rare disease care pathways in the Republic of Ireland: a co-operative model. Orphanet J Rare Dis 2022; 17: 162. doi: 10.1186/s13023-022-02309-6.WardAJMurphyDMarronR.Designing rare disease care pathways in the Republic of Ireland: a co-operative model.2022;17:162. doi:10.1186/s13023-022-02309-6.Open DOISearch in Google Scholar
Beny K, du Sartz de Vigneulles B, Carrouel F, et al. Haemophilia in France: modelisation of the clinical pathway for patients. Int J Environ Res Public Health 2022; 19(2): 646. doi: 10.3390/ijerph19020646.BenyKdu Sartz de VigneullesBCarrouelF.Haemophilia in France: modelisation of the clinical pathway for patients.2022;19(2):646. doi:10.3390/ijerph19020646.Open DOISearch in Google Scholar
Page D. Comprehensive care for hemophilia and other inherited bleeding disorders. Transfus Apher Sci 2019, 58: 565-568. doi: 10.1016/j.transci.2019.08.005.PageD.Comprehensive care for hemophilia and other inherited bleeding disorders.2019,58:565-568. doi:10.1016/j.transci.2019.08.005.Open DOISearch in Google Scholar
Bok A, Noone D, Skouwe-Rasmussen N; EHC Think Tank. Patient agency: key questions and challenges – A report from the 1st workshop of the EHC Think Tank Workstream on Patient Agency. J Haem Pract 2022; 9(1): 27-35. doi: 10.2478/jhp-2022-0004.BokANooneDSkouwe-RasmussenNEHC Think Tank.Patient agency: key questions and challenges – A report from the 1st workshop of the EHC Think Tank Workstream on Patient Agency.2022;9(1):27-35. doi:10.2478/jhp-2022-0004.Open DOISearch in Google Scholar
Goodman M. Systems thinking: what, why, when, where and how? The Systems Thinker. Available from https://thesystemsthinker.com/systems-thinking-what-why-when-where-and-how/ (accessed 27 June 2023).GoodmanM.Systems thinking: what, why, when, where and how?. Available from https://thesystemsthinker.com/systems-thinking-what-why-when-where-and-how/(accessed 27 June 2023).Search in Google Scholar
Gittus M, Chong J, Sutton A, Ong ACM, Fotheringham J. Barriers and facilitators to the implementation of guidelines in rare diseases: a systematic review. Orphanet J Rare Dis 2023; 18: 140. doi: 10.1186/s13023-023-02667-9.GittusMChongJSuttonAOngACMFotheringhamJ.Barriers and facilitators to the implementation of guidelines in rare diseases: a systematic review.2023;18:140. doi:10.1186/s13023-023-02667-9.Open DOISearch in Google Scholar
Rand L, Dunn M, Slade I, et al. Understanding and using patient experiences as evidence in healthcare priority setting. Cost Eff Resour Alloc 2019; 17: 20. doi: 10.1186/s12962-019-0188-1.RandLDunnMSladeI.Understanding and using patient experiences as evidence in healthcare priority setting.2019;17:20. doi:10.1186/s12962-019-0188-1.Open DOISearch in Google Scholar
Facey KM, Rannanheimo P, Batchelor L, Borchardt M, de Cock J. Real-world evidence to support payer/HTA decisions about highly innovative technologies in the EU – actions for stakeholders. Int J Technol Assess Health Care 202; 36: 459-468. doi: 10.1017/S026646232000063X.FaceyKMRannanheimoPBatchelorLBorchardtMde CockJ.Real-world evidence to support payer/HTA decisions about highly innovative technologies in the EU – actions for stakeholders.202;36:459-468. doi:10.1017/S026646232000063X.Open DOISearch in Google Scholar
Zhou Z-Y, Koerper MA, Johnson KA, et al. Burden of illness: direct and indirect costs among persons with hemophilia A in the United States. J Med Econ 2015; 18:6, 457-465. doi: 10.3111/13696998.2015.1016228.ZhouZ-YKoerperMAJohnsonKA.Burden of illness: direct and indirect costs among persons with hemophilia A in the United States.2015;18:6,457-465. doi:10.3111/13696998.2015.1016228.Open DOISearch in Google Scholar
Pearson I, Rothwell B, Olaye A, Knight C. Economic modeling considerations for rare diseases. Value in Health 2018; 21(5): 515-524. doi: 10.1016/j.jval.2018.02.008.PearsonIRothwellBOlayeAKnightC.Economic modeling considerations for rare diseases.2018;21(5):515-524. doi:10.1016/j.jval.2018.02.008.Open DOISearch in Google Scholar
Garrison LP Jr, Jiao B, Dabbous O. Gene therapy may not be as expensive as people think: challenges in assessing the value of single and short-term therapies. J Manag Care Spec Pharm 2021; 27(5): 674-681. doi: 10.18553/jmcp.2021.27.5.674.GarrisonLPJrJiaoBDabbousO.Gene therapy may not be as expensive as people think: challenges in assessing the value of single and short-term therapies.2021;27(5):674-681. doi:10.18553/jmcp.2021.27.5.674.Open DOISearch in Google Scholar
Goodman C, Berntorp E, Wong O, the International Haemophilia Access Strategy Council. Alternative payment models for durable and potentially curative therapies: The case of gene therapy for haemophilia A. Haemophilia 2022; 28(S2): 27-34. doi: 10.1111/hae.14425.GoodmanCBerntorpEWongOthe International Haemophilia Access Strategy Council.Alternative payment models for durable and potentially curative therapies: The case of gene therapy for haemophilia A.2022;28(S2):27-34. doi:10.1111/hae.14425.Open DOISearch in Google Scholar
Bolz-Johnson M, Kenny T, Le Cam Y, Hernando I. Our greatest untapped resource: our patients. J Community Genet 2021; 12: 241-246. doi: 10.1007/s12687-021-00524-5.Bolz-JohnsonMKennyTLe CamYHernandoI.Our greatest untapped resource: our patients.2021;12:241-246. doi:10.1007/s12687-021-00524-5.Open DOISearch in Google Scholar
Wind A, van der Linden C, Hartman E, et al. Patient involvement in clinical pathway development, implementation and evaluation – A scoping review of international literature. Patient Educ Couns 2022; 105 (6) 1441-1448. doi: 10.1016/j.pec.2021.10.007.WindAvan der LindenCHartmanE.Patient involvement in clinical pathway development, implementation and evaluation – A scoping review of international literature.2022;105(6)1441-1448. doi:10.1016/j.pec.2021.10.007.Open DOISearch in Google Scholar
Colvin BT, Astermark J, Fischer K, et al., for the Inter Disciplinary Working Group. European principles of haemophilia care. Haemophilia 2008; 14(2): 361-374. doi: 10.1111/j.1365-2516.2007.01625.x.ColvinBTAstermarkJFischerKfor the Inter Disciplinary Working Group.European principles of haemophilia care.2008;14(2):361-374. doi:10.1111/j.1365-2516.2007.01625.x.Open DOISearch in Google Scholar
Khayatzadeh-Mahani A, Nolte E, Sutherland J, Forest P-G. International experiments with different models of allocating funds to facilitate integrated care: a scoping review protocol. BMJ Open 2018; 8(11): e021374. doi: 10.1136/bmjopen-2017-021374.Khayatzadeh-MahaniANolteESutherlandJForestP-G.International experiments with different models of allocating funds to facilitate integrated care: a scoping review protocol.2018;8(11):e021374. doi:10.1136/bmjopen-2017-021374.Open DOISearch in Google Scholar
Rosell L, Alexandersson N, Hagberg O, Nilbert M. Benefits, barriers and opinions on multidisciplinary team meetings: a survey in Swedish cancer care. BMC Health Serv Res 2018; 18: 249. doi: 10.1186/s12913-018-2990-4.RosellLAlexanderssonNHagbergONilbertM.Benefits, barriers and opinions on multidisciplinary team meetings: a survey in Swedish cancer care.2018;18:249. doi:10.1186/s12913-018-2990-4.Open DOISearch in Google Scholar
Simpson A, Bloom L, Fulop NJ, et al. How are patients with rare diseases and their carers in the UK impacts by the way care is coordinated? An exploratory qualitative interview study. Orphanet J Rare Dis 2021; 16: 76. doi: 10.1186/s13023-020-01664-6.SimpsonABloomLFulopNJ.How are patients with rare diseases and their carers in the UK impacts by the way care is coordinated? An exploratory qualitative interview study.2021;16:76. doi:10.1186/s13023-020-01664-6.Open DOISearch in Google Scholar
Tumiene B, Graessner H. Rare disease care pathways in the EU: from odysseys and labyrinths towards highways. J Community Genet 2021; 12(2): 231-239. doi: 10.1007/s12687-021-00520-0.TumieneBGraessnerH.Rare disease care pathways in the EU: from odysseys and labyrinths towards highways.2021;12(2):231-239. doi:10.1007/s12687-021-00520-0.Open DOISearch in Google Scholar
Colvin BT, Astermark J, Fischer K, et al., for the Inter Disciplinary Working Group. European principles of haemophilia care. Haemophilia 2008; 14(2): 361-374. doi: 10.1111/j.1365-2516.2007.01625.x.ColvinBTAstermarkJFischerKfor the Inter Disciplinary Working Group.European principles of haemophilia care.2008;14(2):361-374. doi:10.1111/j.1365-2516.2007.01625.x.Open DOISearch in Google Scholar
van Balen EC, O’Mahony B, Cnossen MH, et al. Patient-relevant health outcomes for hemophilia care: Development of an international standard outcomes set. Res Pract Thromb Haemost 2021; 6(5): e12488. doi: 10.1002/rth2.12488.van BalenECO’MahonyBCnossenMH.Patientrelevant health outcomes for hemophilia care: Development of an international standard outcomes set.2021;6(5):e12488. doi:10.1002/rth2.12488.Open DOISearch in Google Scholar
Kole A, Faurisson F. Rare diseases social epidemiology: analysis of inequalities. In: Posada de la Paz M, Groft S (eds). Rare Diseases Epidemiology. Advances in Experimental Medicine and Biology vol. 686. Dordrecht: Springer, 2010. doi: 10.1007/978-90-481-9485-8_14.KoleAFaurissonF.Rare diseases social epidemiology: analysis of inequalities. In:Posada de la PazMGroftS(eds).vol.686.Dordrecht:Springer,2010. doi:10.1007/978-90-481-9485-8_14.Open DOISearch in Google Scholar
Weyand AC, James PD. Sexism in the management of bleeding disorders. Res Pract Thromb Haemost 2020; 5(1): 51-54. doi: 10.1002/rth2.12468.WeyandACJamesPD.Sexism in the management of bleeding disorders.2020;5(1):51-54. doi:10.1002/rth2.12468.Open DOISearch in Google Scholar
Di Michele DM, Gibb C, Lefkowitz JM, et al. Severe and moderate haemophilia A and B in US females. Haemophilia 2014; 20(2): e136-143. doi: 10.1111/hae.12364.Di MicheleDMGibbCLefkowitzJM.Severe and moderate haemophilia A and B in US females.2014;20(2):e136-143. doi:10.1111/hae.12364.Open DOISearch in Google Scholar
EURORDIS. Solve-RD infographic on the patient journey to diagnosis. July 2020. Available from https://www.eurordis.org/publications/solve-rd-infographic-on-the-patient-journey-to-diagnosis/ (accessed 19 July 2023).EURORDIS..July2020. Available from https://www.eurordis.org/publications/solve-rd-infographic-on-the-patient-journey-to-diagnosis/(accessed 19 July 2023).Search in Google Scholar
Thorat T, Neumann PJ, Chambers JD. Hemophilia burden of disease: a systematic review of the cost-utility literature for hemophilia. J Manag Care Spec Pharm 2018; 24(7): 632-642. doi: 10.18553/jmcp.2018.24.7.632.ThoratTNeumannPJChambersJD.Hemophilia burden of disease: a systematic review of the cost-utility literature for hemophilia.2018;24(7):632-642. doi:10.18553/jmcp.2018.24.7.632.Open DOISearch in Google Scholar
Pagès-Puigdemont N, Mangues MA, Masip M, et al. Patients’ perspectives of medication adherence in chronic conditions: a qualitative study. Adv Ther 2016; 33: 1740-1754. doi: 10.1007/s12325-016-0394-6.Pagès-PuigdemontNManguesMAMasipM.Patients’ perspectives of medication adherence in chronic conditions: a qualitative study.2016;33:1740-1754. doi:10.1007/s12325-016-0394-6.Open DOISearch in Google Scholar
Zimlichman E, Nicklin W, Aggarwal R, Bates DW. Health care 2030: the coming transformation. NEJM Catalyst 2021, March 3. doi: 10,.1056/CAT.20.0569.ZimlichmanENicklinWAggarwalRBatesDW.Health care 2030: the coming transformation.2021,March3. doi:10,.1056/CAT.20.0569.Open DOISearch in Google Scholar
European Commission Directorate-General for Food and Health Safety. Proposal for a Regulation – The European Health Data Space. COM(2022) 197/2. 3 May 2022. Available from https://health.ec.europa.eu/publications/proposal-regulation-european-health-data-space_en (accessed 12 July 2023).European Commission Directorate-General for Food and Health Safety..COM(2022) 197/2.3May2022. Available from https://health.ec.europa.eu/publications/proposal-regulation-european-health-data-space_en(accessed 12 July 2023).Search in Google Scholar
European Commission. Proposal for a Regulation of the European Parliament and of the Council Laying Down Harmonised Rules on Artificial Intelligence (Artificial Intelligence Act) and Amending Certain Union Legislative Acts. 2021/0106 (COD). 21 April 2021. Available from https://artifícialintelligenceact.eu/the-act/ (accessed 12 July 2023).European Commission.. 2021/0106 (COD).21April2021. Available from https://artifícialintelligenceact.eu/the-act/(accessed 12 July 2023).Search in Google Scholar
Mittelstadt BD, Floridi L. The ethics of big data: current and foreseeable issues in biomedical contexts. Sci Eng Ethics 2016; 22(2): 303-41. doi: 10.1007/s11948-015-9652-2.MittelstadtBDFloridiL.The ethics of big data: current and foreseeable issues in biomedical contexts.2016;22(2):303-41. doi:10.1007/s11948-015-9652-2.Open DOISearch in Google Scholar
Petracca F, Tempre R, Cucciniello M, et al. An electronic patient-reported outcome mobile app for data collection in type a hemophilia: design and usability study. JMIR Form Res 2021; 5(12): e25071. doi: 10.2196/25071.PetraccaFTempreRCuccinielloM.An electronic patient-reported outcome mobile app for data collection in type a hemophilia: design and usability study.2021;5(12):e25071. doi:10.2196/25071.Open DOISearch in Google Scholar
Donald A, Cizer H, Finnegan N, et al. Measuring disease activity and patient experience remotely using wearable technology and a mobile phone app: outcomes from a pilot study in Gaucher disease. Orphanet J Rare Dis 2019; 14(1): 212. doi: 10.1186/s13023-019-1182-6.DonaldACizerHFinneganN.Measuring disease activity and patient experience remotely using wearable technology and a mobile phone app: outcomes from a pilot study in Gaucher disease.2019;14(1):212. doi:10.1186/s13023-019-1182-6.Open DOISearch in Google Scholar
Lehne M, Sass J, Essenwanger A, Schepers J, Thun S. Why digital medicine depends on interoperability. NPJ Digit Med 2019; 2: 79. doi: 10.1038/s41746-019-0158-1.LehneMSassJEssenwangerASchepersJThunS.Why digital medicine depends on interoperability.2019;2:79. doi:10.1038/s41746-019-0158-1.Open DOISearch in Google Scholar
Gomes M, Murray E, Rafery J. Economic evaluation of digital health interventions: methodological issues and recommendations for practice. Pharmacoeconomics 2022; 40(4): 367-378. doi: 10.1007/s40273-022-01130-0.GomesMMurrayERaferyJ.Economic evaluation of digital health interventions: methodological issues and recommendations for practice.2022;40(4):367-378. doi:10.1007/s40273-022-01130-0.Open DOISearch in Google Scholar
Alami H, Gagnon M-P, Fortin J-P. Digital health and the challenge of health systems transformation. Mhealth 2017; 3: 31. doi: 10.21037/mhealth.2017.07.02.AlamiHGagnonM-PFortinJ-P.Digital health and the challenge of health systems transformation.2017;3:31. doi:10.21037/mhealth.2017.07.02.Open DOISearch in Google Scholar
Castro R, de Chalendar M, Vajda I, et al. Rare diseases. In: Amelung V, Stein V, Suter E, et al. (eds). Handbook Integrated Care. 2020. Springer, Cham. doi: 10.1007/978-3-030-69262-9_44.CastroRde ChalendarMVajdaI.Rare diseases. In:AmelungVSteinVSuterE. (eds)..2020.Springer,Cham. doi:10.1007/978-3-030-69262-9_44.Open DOISearch in Google Scholar
van Galen K, Lavin M, Skouw-Rasmussen N, et al. European principles of care for women and girls with inherited bleeding disorders. Haemophilia 2021; 27(5): 837-847. doi: 10.1111/hae.14379.van GalenKLavinMSkouw-RasmussenN.European principles of care for women and girls with inherited bleeding disorders.2021;27(5):837-847. doi:10.1111/hae.14379.Open DOISearch in Google Scholar
Halley MC, Halverson CME, Tabor HK, Goldenberg AJ. Rare disease, advocacy and justice: intersecting disparities in research and clinical care. Am J Bioethics 2023; 7: 17-26. doi: 10.1080/15265161.2023.2207500.HalleyMCHalversonCMETaborHKGoldenbergAJ.Rare disease, advocacy and justice: intersecting disparities in research and clinical care.2023;7:17-26. doi:10.1080/15265161.2023.2207500.Open DOISearch in Google Scholar
De Santis M, Hervas C, Weinman A, Bosi G, Bottarelli V. Patient empowerment of people living with rare diseases. Its contribution to sustainable and resilient healthcare systems. Ann Ist Super Sanit 2019; 55(3): 283-291. doi: 10.4415/ANN_19_03_15.De SantisMHervasCWeinmanABosiGBottarelliV.Patient empowerment of people living with rare diseases. Its contribution to sustainable and resilient healthcare systems.2019;55(3):283-291. doi:10.4415/ANN_19_03_15.Open DOISearch in Google Scholar
Leanza Y, Boivin I, Rosenberg E. Interruptions and resistance: A comparison of medical consultations with family and trained interpreters. Soc Sci Med 2010; 70(12): 1888-1895. doi: 10.1016/j.socscimed.2010.02.036.LeanzaYBoivinIRosenbergE.Interruptions and resistance: A comparison of medical consultations with family and trained interpreters.2010;70(12):1888-1895. doi:10.1016/j.socscimed.2010.02.036.Open DOISearch in Google Scholar
EHC. Think Tank. Available from https://ehcthinktank.eu (accessed 19 July 2023).EHC.. Available from https://ehcthinktank.eu(accessed 19 July 2023).Search in Google Scholar
Chatham House. Chatham House rule. Available from https://www.chathamhouse.org/about-us/chatham-house-rule (accessed 19 July 2023).Chatham House.. Available from https://www.chathamhouse.org/about-us/chatham-house-rule(accessed 19 July 2023).Search in Google Scholar